Haynes BF - Search Results

1

Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial.

Gottardo R, Bailer RT, Korber BT, Gnanakaran S, Phillips J, Shen X, Tomaras GD, Turk E, Imholte G, Eckler L, Wenschuh H, Zerweck J, Greene K, Gao H, Berman PW, Francis D, Sinangil F, Lee C, Nitayaphan S, Rerks-Ngarm S, Kaewkungwal J, Pitisuttithum P, Tartaglia J, Robb ML, Michael NL, Kim JH, Zolla-Pazner S, Haynes BF, Mascola JR, Self S, Gilbert P, Montefiori DC. Gottardo R, et al. Among authors: haynes bf. PLoS One. 2013 Sep 26;8(9):e75665. doi: 10.1371/journal.pone.0075665. eCollection 2013. PLoS One. 2013. PMID: 24086607 Free PMC article.

2

HIV type 1 V3 region primer-induced antibody suppression is overcome by administration of C4-V3 peptides as a polyvalent immunogen.

Haynes BF, Moody MA, Heinley CS, Korber B, Millard WA, Scearce RM. Haynes BF, et al. AIDS Res Hum Retroviruses. 1995 Feb;11(2):211-21. doi: 10.1089/aid.1995.11.211. AIDS Res Hum Retroviruses. 1995. PMID: 7742036

3

Vaccine-elicited V3 loop-specific antibodies in rhesus monkeys and control of a simian-human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate envelope.

Letvin NL, Robinson S, Rohne D, Axthelm MK, Fanton JW, Bilska M, Palker TJ, Liao HX, Haynes BF, Montefiori DC. Letvin NL, et al. Among authors: haynes bf. J Virol. 2001 May;75(9):4165-75. doi: 10.1128/JVI.75.9.4165-4175.2001. J Virol. 2001. PMID: 11287566 Free PMC article.

4

HIV vaccine development at Duke University Medical Center.

Haynes BF, Liao HX, Staats HF, Alam MS, Weinhold KJ, Montefiori DC. Haynes BF, et al. Immunol Res. 2000;22(2-3):263-9. doi: 10.1385/ir:22:2-3:263. Immunol Res. 2000. PMID: 11339361 Review.

5

Increased immunogenicity of HIV envelope subunit complexed with alpha2-macroglobulin when combined with monophosphoryl lipid A and GM-CSF.

Liao HX, Cianciolo GJ, Staats HF, Scearce RM, Lapple DM, Stauffer SH, Thomasch JR, Pizzo SV, Montefiori DC, Hagen M, Eldridge J, Haynes BF. Liao HX, et al. Among authors: haynes bf. Vaccine. 2002 May 22;20(17-18):2396-403. doi: 10.1016/s0264-410x(02)00090-7. Vaccine. 2002. PMID: 12009296

6

Immunogenicity of constrained monoclonal antibody A32-human immunodeficiency virus (HIV) Env gp120 complexes compared to that of recombinant HIV type 1 gp120 envelope glycoproteins.

Liao HX, Alam SM, Mascola JR, Robinson J, Ma B, Montefiori DC, Rhein M, Sutherland LL, Scearce R, Haynes BF. Liao HX, et al. Among authors: haynes bf. J Virol. 2004 May;78(10):5270-8. doi: 10.1128/jvi.78.10.5270-5278.2004. J Virol. 2004. PMID: 15113908 Free PMC article.

7

Centralized immunogens as a vaccine strategy to overcome HIV-1 diversity.

Gao F, Korber BT, Weaver E, Liao HX, Hahn BH, Haynes BF. Gao F, et al. Among authors: haynes bf. Expert Rev Vaccines. 2004 Aug;3(4 Suppl):S161-8. doi: 10.1586/14760584.3.4.s161. Expert Rev Vaccines. 2004. PMID: 15285714 Review.

8

Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group m consensus envelope glycoprotein.

Gao F, Weaver EA, Lu Z, Li Y, Liao HX, Ma B, Alam SM, Scearce RM, Sutherland LL, Yu JS, Decker JM, Shaw GM, Montefiori DC, Korber BT, Hahn BH, Haynes BF. Gao F, et al. Among authors: haynes bf. J Virol. 2005 Jan;79(2):1154-63. doi: 10.1128/JVI.79.2.1154-1163.2005. J Virol. 2005. PMID: 15613343 Free PMC article.

9

Comparison of HIV Type 1 ADA gp120 monomers versus gp140 trimers as immunogens for the induction of neutralizing antibodies.

Kim M, Qiao ZS, Montefiori DC, Haynes BF, Reinherz EL, Liao HX. Kim M, et al. Among authors: haynes bf. AIDS Res Hum Retroviruses. 2005 Jan;21(1):58-67. doi: 10.1089/aid.2005.21.58. AIDS Res Hum Retroviruses. 2005. PMID: 15665645

10

Analysis of HIV-1 subtype B third variable region peptide motifs for induction of neutralizing antibodies against HIV-1 primary isolates.

Haynes BF, Ma B, Montefiori DC, Wrin T, Petropoulos CJ, Sutherland LL, Scearce RM, Denton C, Xia SM, Korber BT, Liao HX. Haynes BF, et al. Virology. 2006 Feb 5;345(1):44-55. doi: 10.1016/j.virol.2005.08.042. Epub 2005 Oct 20. Virology. 2006. PMID: 16242749 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

769 results

Search Page